Beta Tester ProgramDescription: Vector Laboratories, a pioneer of innovative proteomic and glycomic research solutions, has partnered with Navinci Diagnostics, leader of innovative in situ proximity ligation assay (isPLA)-based solutions, to develop a novel assay for spatial proteomics and glycomics applications, such as biomarker discovery and validation. Such applications will empower researchers to understand the glycosylation state of specific protein targets in a tissue. Vector Laboratories is preparing for the launch of this assay in June 2025. In preparation for the launch we are rolling out a Beta tester program. During the program, we will supply the assay kits, protocols and support, and request feedback and data from you by April 2025. We are reaching out the SfG community to invite researchers to participate in the Beta tester program. We are looking forward to hearing from the community and please feel free to reach out if you have any questions about the program.
Shuhui Chen, PhD Vector Laboratories, Inc. Posted January 28, 2025 |
